| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |